Diagnostic tests for diseases that cannot be treated or cannot be treated well are a delicate matter. This is particularly true for Alzheimer’s disease, the most common form of dementia. Antibodies that are intended to help against the progression of pathological forgetfulness have recently become available on the market in the USA. Such approval is also imminent in Europe. However, no cure is yet possible with the help of these medications; at best, the cognitive impairments can be delayed somewhat. In addition, the side effects of the drugs are sometimes significant and long-term studies are lacking.
A test for Alzheimer’s: Will dementia soon be diagnosed in the blood? – Health
